Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxia-inducible factors (HIFs) are transcription factors that play a critical role in cellular adaptation to low oxygen conditions (hypoxia). They regulate the expression of genes involved in angiogenesis, glucose metabolism, cell survival, and erythropoiesis. HIFs are heterodimers consisting of an oxygen-sensitive alpha subunit (e.g., HIF-1alpha, HIF-2alpha) and a constitutively expressed beta subunit (HIF-1beta). Under normoxic conditions, HIF-alpha subunits are hydroxylated by prolyl hydroxylases (PHDs), leading to their ubiquitination and proteasomal degradation. In hypoxia, PHDs are inhibited, resulting in HIF-alpha stabilization, dimerization with HIF-1beta, and translocation to the nucleus, where they bind to hypoxia response elements (HREs) in the promoters of target genes.
HIF inhibitors block the transcriptional activity of HIFs by preventing DNA binding or interfering with HIF subunit dimerization. PHIs stabilize HIF-alpha subunits at normal oxygen levels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxia-Inducible Factors (HIFs).